| 耐多药结核病控制策略的研究进展 |
| |
| 引用本文： | 戴冠群. 耐多药结核病控制策略的研究进展[J]. 医学综述, 2010, 16(15): 2241-2243 |
| |
| 作者姓名： | 戴冠群 |
| |
| 作者单位： | 南京医科大学第一附属医院呼吸内科,南京,210029 |
| |
| 基金项目： | 国家科技重大专项"十一五"计划 |
| |
| 摘 要： | 结核分枝杆菌作为最重要的传染性病原体之一,其引起的结核病已经成为全球性的社会公共卫生问题。结核分枝杆菌耐药性的发生,是引起结核病治疗失败以及结核病患者死亡的重要危险因素。耐多药结核病(MDR-TB)的出现和流行是造成结核病疫情回升的主要原因之一,并且对于结核病的控制形成了障碍。随着全球范围内对于MDR-TB的日益重视,各种预防和治疗MDR-TB的新观点和新方法不断被提出。现就近年来MDR-TB控制策略方面的研究进展予以综述。
|
| 关 键 词： | 结核 耐多药性 控制 |
Development of Strategies Controlling Multidrug-resistant Tuberculosis |
| |
| DAI Guan-qun. Development of Strategies Controlling Multidrug-resistant Tuberculosis[J]. Medical Recapitulate, 2010, 16(15): 2241-2243 |
| |
| Authors: | DAI Guan-qun |
| |
| Affiliation: | DAI Guan-qun,XIE Wei-ping,WANG Hong.(Department of Respiratory Medicine,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China) |
| |
| Abstract: | As one of the most important infectious pathogen,mycobacterium tuberculosis,the cause of tuberculosis,has aroused global social and public health concerns.Resistance of mycobacterium tuberculosis to anti-tuberculosis drugs is an important risk factor for treatment failure and death.Multidrug-resistant tuberculosis(MDR-TB)leads to the epidemic tuberculosis recurrence,which hinders the controlling of tuberculosis.With more attentions paid to MDR-TB worldwide,new viewpoints and methods have been proposed.This ... |
| |
| Keywords: | Tuberculosis Multidrug resistance Control |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
